Development of Delivery Systems (DDS)
The DDS Group is mainly focused on the development of noninvasive and minimally invasive drug delivery systems across the biological barriers and also on technologies or devices to deliver non-drug products (including food supplements and cosmetics).
DDS efforts are towards the successful delivery of active agents in a controlled and targeted manner and the development of advanced delivery systems for a variety of applications (cancer, diabetes and infectious diseases).
DDS research includes the development of micro- and nanoparticle delivery systems, solid and semi-solid dosage forms, formulation of lipid-based carrier, skin implants and the use of clays for drug and non-drug delivery.
DDS Group gathers a team of researchers with established collaborations with recognized national and international universities, research centers and the pharmaceutical/food supplements/cosmetic industries.